Linical Co

Linical Co Operating Cash Flow

The Operating Cash Flow of Linical Co (2183.T) as of Nov 8, 2026 is -1.52 B JPY. In the previous year, Operating Cash Flow was 605.10 M JPY — a change of -351.51% (lower).

Operating Cash Flow

-1.52 BJPY

YoY

-351.51%

Last updated:

Operating Cash Flow of Linical Co is 2026 -1.52 B JPY. Operating Cash Flow of Linical Co was 2025 605.10 M JPY. It decreases by -351.51% lower compared to the previous year.

The Linical Co Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2019
-791.66 M JPY
Jan 1, 2020
1.19 B JPY
Jan 1, 2021
23.61 M JPY
Jan 1, 2022
1.63 B JPY
Jan 1, 2023
1.84 B JPY
Jan 1, 2024
1.11 B JPY
Jan 1, 2025
605.10 M JPY
Jan 1, 2026
-1.52 B JPY
The Linical Co Operating Cash Flow history
YEAROperating Cash FlowYoY
-1.52 BJPY-351.51%
605.10 MJPY-45.36%
1.11 BJPY-39.80%
1.84 BJPY+12.74%
1.63 BJPY+6,811.45%
23.61 MJPY-98.02%
1.19 BJPY-250.61%
-791.66 MJPY-158.21%
1.36 BJPY-40.65%
2.29 BJPY+26.11%
1.82 BJPY+163.35%
690.01 MJPY+176.88%
249.21 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Linical Co Stock analysis

What does Linical Co do? Linical Co., Ltd. generates revenue through two distinct business segments, the CRO segment and the Pharmaceutical Sales Support segment. The CRO segment provides contract monitoring, quality management, and consulting services specifically for phase II and phase III in drug development processes. These services are delivered to pharmaceutical companies as part of pharmaceutical contract research projects. The Pharmaceutical Sales Support segment focuses on the downstream market by providing pharmaceutical sales support for medical institutions. The company operates these businesses from its headquarters in Osaka, Osaka-Fu, leveraging its workforce of 759 full-time employees to deliver these specialized services. Linical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linical Co stock

Operating Cash Flow of Linical Co is -1.52 B JPY in 2026.

Operating Cash Flow of Linical Co changed from 605.10 M JPY to -1.52 B JPY, representing a -351.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Linical Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Linical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Linical Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Linical Co